ASSESSMENT OF PHAGE DISPLAY AS A METHOD TO GENERATE GLP-1 ANALOGS

被引：0
|
作者：
GARRARD, L
RUIS, N
TAM, C
ANDY, R
LUSKEY, K
机构：
来源：
DIGESTION | 1993年 / 54卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：393 / 394
页数：2
相关论文
共 50 条
  • [41] Pulmonary administration of GLP-1 (GLP-1 technosphere powder) II: Dynamics
    Costello, D.
    Baughman, R.
    Levy, B.
    van Vliet, A.
    Price, A.
    Diaz, M.
    Damico, C.
    Richardson, P.
    DIABETOLOGIA, 2008, 51 : S346 - S347
  • [42] Synthetic peptide analogs compared with phage display
    Martin, LM
    Messmer, B
    Thaler, D
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 172 - 173
  • [43] GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
    Singh, Anmol
    Sohal, Aalam
    Batta, Akash
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (48)
  • [44] Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment
    Trapp, Stefan
    Brierley, Daniel, I
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 557 - 570
  • [45] Topography of the GLP-1/GLP-1 receptor system in the spinal cord of male mice
    Ruska, Yvette
    Csibi, Andrea
    Doroghazi, Beata
    Szilvasy-Szabo, Anett
    Mohacsik, Petra
    Kornyei, Zsuzsanna
    Denes, Adam
    Kadar, Andrea
    Puskar, Zita
    Hrabovszky, Erik
    Gereben, Balazs
    Wittmann, Gabor
    Fekete, Csaba
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1
    Hager, Marlies V.
    Clydesdale, Lachlan
    Gellman, Samuel H.
    Sexton, Patrick M.
    Wootten, Denise
    BIOCHEMICAL PHARMACOLOGY, 2017, 136 : 99 - 108
  • [47] Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    Torekov, S. S.
    Madsbad, S.
    Holst, J. J.
    OBESITY REVIEWS, 2011, 12 (08) : 593 - 601
  • [48] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [49] Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal GLP-1 receptors
    Gong, Nian
    Fan, Hui
    Ma, Ai-Niu
    Xiao, Qi
    Wang, Yong-Xiang
    NEUROPHARMACOLOGY, 2014, 84 : 31 - 45
  • [50] Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus
    Vilsboll, Tina
    Knop, Filip K.
    BIODRUGS, 2008, 22 (04) : 251 - 257
12345